GIS:FRA
Gilead Sciences, Inc
€१३०.८८
arrow_upward
+०.२८%(+०.३६) १ दि
९ ऑक्टो, ८:०१:१० AM [GMT]+२ · EUR
search
सर्व सिम्बॉल
| सिम्बॉल | किंमत | बदल | % बदल |
|---|
insights_autoGIS साठी टॉप इनसाइट जनरेट करत आहे...
उघडा
€१३०.८८
उच्च
€१३०.८८
कमी
€१३०.८८
मार्केट कॅप
१.८७ खर्व
सरासरी उलाढाल
३९८.००
उलाढाल
०.००
५२ आठवड्यांतील उच्चांक
€१३४.५८
५२ आठवड्यांतील नीचांक
€९७.७९
कर्मचाऱ्यांची संख्या
१७ ह
उघडा
€१३०.८८
उच्च
€१३०.८८
कमी
€१३०.८८
मार्केट कॅप
१.८७ खर्व
सरासरी उलाढाल
३९८.००
उलाढाल
०.००
५२ आठवड्यांतील उच्चांक
€१३४.५८
५२ आठवड्यांतील नीचांक
€९७.७९
कर्मचाऱ्यांची संख्या
१७ ह
बातम्यांच्या स्टोरी
वेब स्रोत आणि बातमी भागीदारांकडून
AD HOC NEWS
·
२ तासांपूर्वी
RBC raises target for Gilead Sciences stock to USD 126.00
Simply Wall Street
·
९ तासांपूर्वी
How Earnings Beat At Gilead Sciences Stock Has Changed Its Investment Story
MarketBeat
·
१ दिवसापूर्वी
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
GuruFocus
·
२ दिवसांपूर्वी
U.S. Stocks Slip Ahead of Fed Minutes; Gilead Sciences (GILD) Ga
प्रोफाइल
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
Gilead Sciences, Inc बद्दल
CEOडॅनियेल ओडे
कर्मचारी१७ ह
स्थापना२२ जून, १९८७
मुख्यालयेFoster City, कॅलिफोर्निया, संयुक्त राष्ट्र
क्षेत्र-
वेबसाइटgilead.com